|Estimated EPS Growth
Harvard Bioscience Inc. rank is 220
|Top Industry Values
Harvard Bioscience Inc. rank is 235
Harvard Bioscience Inc. has a PEG Value of $4.67. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 27.51% in the next year. Among companies with a PEG Value above the current stock price, Harvard Bioscience Inc. is ranked 424.
The StockSelector Value for Harvard Bioscience Inc. is $8.53. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Harvard Bioscience Inc. is ranked 539.
Harvard Bioscience Inc. rank is 1382
|Historic Revenue Growth
Harvard Bioscience Inc. rank is 2323
Within the past 90 days Harvard Bioscience Inc. has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
|Negative Past Growth
Harvard Bioscience Inc. rank is 810
|Negative Net Margin
Harvard Bioscience Inc. rank is 980